The role of Hevin in cancer is likely complex: its expression has been shown to be correlated with invasive gliomas [50] yet it is highly downregulated in other malignancies and has been described as a tumour suppressor gene [24, 51]. The gene discussed is SPARCL1; the disease is cancer.